Effects of erythropoietin on left ventricular hypertrophy in adults with severe chronic renal failure and hemoglobin <10 g/dL
- 1 August 2005
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 68 (2) , 788-795
- https://doi.org/10.1111/j.1523-1755.2005.00458.x
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- New Avenues of Exploration for ErythropoietinJAMA, 2005
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobinAmerican Journal of Kidney Diseases, 1999
- Reversal of Anemia by Erythropoietin Therapy Retards the Progression of Chronic Renal Failure, Especially in Nondiabetic PatientsNephron, 1997
- Outcome and risk factors for left ventricular disorders in chronic uraemiaNephrology Dialysis Transplantation, 1996
- Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factorsKidney International, 1995
- Impact of left ventricular hypertrophy on survival in end-stage renal diseaseKidney International, 1989
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.Circulation, 1977
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976